Our pioneering LiDia-SEQ™ DNA sequencing system will host a range of tests that will provide vital, actionable information to clinicians at the point-of-need, helping save patients’ lives.
Our pioneering LiDia-SEQ™ DNA sequencing system will host a range of tests that will provide vital, actionable information to clinicians at the point-of-need, helping save patients’ lives.
LiDia-SEQ™ combines powerful analytical capability and accurate results with speed and simplicity of use.
Diagnostic tests are in development for multiple healthcare applications where rapid point-of-need diagnostics are of critical need:
Easy to operate
providing 24/7
diagnostics
Results in 3-4 hours
at the point of need
Highly sensitive and
specific
DNAe’s initial focus is on developing infectious disease diagnostics, where speed and DNA sequence information can make the difference between life and death. This includes a range of tests, starting with a groundbreaking test for bloodstream infections (BSI) and antimicrobial resistance (AMR), which uses whole blood specimens to detect and identify infections that lead to sepsis.
The diagnostic will rapidly identify what infection a patient has, as well as any associated antimicrobial resistance. This will provide clinicians with actionable information to help select the appropriate antibiotics to treat the disease.